These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37664639)

  • 1. The effect of GelDex-S58 hydrogel on anti-conjunctival scarring after glaucoma filtration surgery.
    Lin Y; Luo W; Jiang B; Lin Q; Tang M; Li X; Xie L
    iScience; 2023 Sep; 26(9):107633. PubMed ID: 37664639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Chitosan/Aptamer Targeting TGF-β Receptor II Thermo-Sensitive Gel for Scarring in Rat Glaucoma Filtration Surgery.
    Zhu X; Xu D; Zhu X; Li L; Li H; Guo F; Chen X; Tan Y; Xie L
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5465-76. PubMed ID: 26284552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model.
    Lin QY; Li XJ; Leng Y; Zhu XM; Tang M; Lin Y; Luo WD; Jiang BC; Chen X; Xie L
    Int J Ophthalmol; 2022; 15(5):690-700. PubMed ID: 35601180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TβR II-targeted aptamer S58 prevents fibrosis after glaucoma filtration surgery.
    Li X; Leng Y; Li X; Wang Y; Luo P; Zhang C; Wang Z; Yue X; Shen C; Chen L; Liu Z; Shi C; Xie L
    Aging (Albany NY); 2020 May; 12(10):8837-8857. PubMed ID: 32452828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II.
    Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
    Int J Pharm; 2013 Nov; 456(2):499-507. PubMed ID: 23999222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.
    Ko JA; Komatsu K; Minamoto A; Kondo S; Okumichi H; Hirooka K; Kiuchi Y
    Curr Eye Res; 2023 Sep; 48(9):826-835. PubMed ID: 37216470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.
    Cordeiro MF; Gay JA; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2225-34. PubMed ID: 10476787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery.
    Cheng WS; Chen CL; Chen JT; Lin LT; Pao SI; Chen YH; Lu DW
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32993110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
    Ibrahim DG; Ko JA; Iwata W; Okumichi H; Kiuchi Y
    Cell Biochem Funct; 2019 Mar; 37(2):113-124. PubMed ID: 30773659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation.
    Seet LF; Lee WS; Su R; Finger SN; Crowston JG; Wong TT
    Mol Med; 2011; 17(5-6):557-67. PubMed ID: 21229189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring.
    Cordeiro MF; Reichel MB; Gay JA; D'Esposita F; Alexander RA; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1975-82. PubMed ID: 10440251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
    Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collecting and deactivating TGF-β1 hydrogel for anti-scarring therapy in post-glaucoma filtration surgery.
    Wang R; Chen B; Wei H; Yan W; Wu Y; Wang C; Zhang B; Liu F; Tian H; Chen X; Tian W
    Mater Today Bio; 2022 Mar; 14():100260. PubMed ID: 35514434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel aptamer targeting TGF-β receptor II inhibits transdifferentiation of human tenon's fibroblasts into myofibroblast.
    Zhu X; Li L; Zou L; Zhu X; Xian G; Li H; Tan Y; Xie L
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6897-903. PubMed ID: 22899759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy.
    Igarashi N; Honjo M; Aihara M
    Exp Eye Res; 2021 Feb; 203():108421. PubMed ID: 33359326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
    Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Survivin and Transcription Factor FOXP1 in Scarring After Glaucoma Surgery.
    Wang X; Huang Z; Zeng L; Jin X; Yan A; Zhang Y; Tan W
    Transl Vis Sci Technol; 2022 Feb; 11(2):19. PubMed ID: 35142784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.
    Mead AL; Wong TT; Cordeiro MF; Anderson IK; Khaw PT
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3394-401. PubMed ID: 12882787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
    Wong TT; Mead AL; Khaw PT
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2018-22. PubMed ID: 15914618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.
    Kottler UB; Jünemann AG; Aigner T; Zenkel M; Rummelt C; Schlötzer-Schrehardt U
    Exp Eye Res; 2005 Jan; 80(1):121-34. PubMed ID: 15652533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.